FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2945478885> ?p ?o ?g. }

• W2945478885 endingPage "434" @default.
• W2945478885 startingPage "424" @default.
• W2945478885 abstract "The 2016 World Health Organization classification defines diffuse large B-cell lymphoma (DLBCL) subtypes based on Epstein-Barr virus (EBV) infection and oncogenic rearrangements of MYC/BCL2/BCL6 as drivers of lymphomagenesis. A subset of DLBCL, however, is characterized by activating mutations in MYD88/CD79B We investigated whether MYD88/CD79B mutations could improve the classification and prognostication of DLBCL. In 250 primary DLBCL, MYD88/CD79B mutations were identified by allele-specific polymerase chain reaction or next-generation-sequencing, MYC/BCL2/BCL6 rearrangements were analyzed by fluorescence in situ hybridization, and EBV was studied by EBV-encoded RNA in situ hybridization. Associations of molecular features with clinicopathologic characteristics, outcome, and prognosis according to the International Prognostic Index (IPI) were investigated. MYD88 and CD79B mutations were identified in 29.6% and 12.3%, MYC, BCL2, and BCL6 rearrangements in 10.6%, 13.6%, and 20.3%, and EBV in 11.7% of DLBCL, respectively. Prominent mutual exclusivity between EBV positivity, rearrangements, and MYD88/CD79B mutations established the value of molecular markers for the recognition of biologically distinct DLBCL subtypes. MYD88-mutated DLBCL had a significantly inferior 5-year overall survival than wild-type MYD88 DLBCL (log-rank; P=0.019). DLBCL without any of the studied aberrations had superior overall survival compared to cases carrying ≥1 aberrancy (log-rank; P=0.010). MYD88 mutations retained their adverse prognostic impact upon adjustment for other genetic and clinical variables by multivariable analysis and improved the prognostic performance of the IPI. This study demonstrates the clinical utility of defining MYD88-mutated DLBCL as a distinct molecular subtype with adverse prognosis. Our data call for sequence analysis of MYD88 in routine diagnostics of DLBCL to optimize classification and prognostication, and to guide the development of improved treatment strategies." @default.
• W2945478885 created "2019-05-29" @default.
• W2945478885 creator A5003531307 @default.
• W2945478885 creator A5013510947 @default.
• W2945478885 creator A5013577389 @default.
• W2945478885 creator A5017560439 @default.
• W2945478885 creator A5018665094 @default.
• W2945478885 creator A5019480225 @default.
• W2945478885 creator A5024047541 @default.
• W2945478885 creator A5032324734 @default.
• W2945478885 creator A5033225491 @default.
• W2945478885 creator A5035092788 @default.
• W2945478885 creator A5036293139 @default.
• W2945478885 creator A5043964506 @default.
• W2945478885 creator A5044070520 @default.
• W2945478885 creator A5059779561 @default.
• W2945478885 creator A5061642557 @default.
• W2945478885 creator A5065546672 @default.
• W2945478885 creator A5070476948 @default.
• W2945478885 creator A5071082159 @default.
• W2945478885 creator A5085973229 @default.
• W2945478885 creator A5090728434 @default.
• W2945478885 date "2019-05-23" @default.
• W2945478885 modified "2023-10-02" @default.
• W2945478885 title "<i>MYD88</i> mutations identify a molecular subgroup of diffuse large B-cell lymphoma with an unfavorable prognosis" @default.
• W2945478885 cites W1020989877 @default.
• W2945478885 cites W1038865554 @default.
• W2945478885 cites W1971211622 @default.
• W2945478885 cites W1979816280 @default.
• W2945478885 cites W2033260061 @default.
• W2945478885 cites W2062683665 @default.
• W2945478885 cites W2090740703 @default.
• W2945478885 cites W2095737226 @default.
• W2945478885 cites W2097403264 @default.
• W2945478885 cites W2100197564 @default.
• W2945478885 cites W2114691684 @default.
• W2945478885 cites W2116382435 @default.
• W2945478885 cites W2138484914 @default.
• W2945478885 cites W2141344114 @default.
• W2945478885 cites W2147246240 @default.
• W2945478885 cites W2158267770 @default.
• W2945478885 cites W2171356556 @default.
• W2945478885 cites W2233049419 @default.
• W2945478885 cites W2233325508 @default.
• W2945478885 cites W2266154500 @default.
• W2945478885 cites W2310716991 @default.
• W2945478885 cites W2315924559 @default.
• W2945478885 cites W2337750191 @default.
• W2945478885 cites W2525478941 @default.
• W2945478885 cites W2527050229 @default.
• W2945478885 cites W2560151975 @default.
• W2945478885 cites W2575036026 @default.
• W2945478885 cites W2579884965 @default.
• W2945478885 cites W2587403681 @default.
• W2945478885 cites W2611611922 @default.
• W2945478885 cites W2617968907 @default.
• W2945478885 cites W2625473279 @default.
• W2945478885 cites W2746315886 @default.
• W2945478885 cites W2752679333 @default.
• W2945478885 cites W2762450632 @default.
• W2945478885 cites W2770680178 @default.
• W2945478885 cites W2771669175 @default.
• W2945478885 cites W2790348403 @default.
• W2945478885 cites W2793383418 @default.
• W2945478885 cites W2797584152 @default.
• W2945478885 cites W2801763724 @default.
• W2945478885 cites W2802100113 @default.
• W2945478885 cites W2806814319 @default.
• W2945478885 cites W2807906520 @default.
• W2945478885 cites W2808005169 @default.
• W2945478885 cites W2809201980 @default.
• W2945478885 cites W2809654973 @default.
• W2945478885 cites W2888203943 @default.
• W2945478885 cites W2984776263 @default.
• W2945478885 cites W4205736005 @default.
• W2945478885 cites W94592798 @default.
• W2945478885 doi "https://doi.org/10.3324/haematol.2018.214122" @default.
• W2945478885 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7012469" @default.
• W2945478885 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31123031" @default.
• W2945478885 hasPublicationYear "2019" @default.
• W2945478885 type Work @default.
• W2945478885 sameAs 2945478885 @default.
• W2945478885 citedByCount "44" @default.
• W2945478885 countsByYear W29454788852019 @default.
• W2945478885 countsByYear W29454788852020 @default.
• W2945478885 countsByYear W29454788852021 @default.
• W2945478885 countsByYear W29454788852022 @default.
• W2945478885 countsByYear W29454788852023 @default.
• W2945478885 crossrefType "journal-article" @default.
• W2945478885 hasAuthorship W2945478885A5003531307 @default.
• W2945478885 hasAuthorship W2945478885A5013510947 @default.
• W2945478885 hasAuthorship W2945478885A5013577389 @default.
• W2945478885 hasAuthorship W2945478885A5017560439 @default.
• W2945478885 hasAuthorship W2945478885A5018665094 @default.
• W2945478885 hasAuthorship W2945478885A5019480225 @default.
• W2945478885 hasAuthorship W2945478885A5024047541 @default.
• W2945478885 hasAuthorship W2945478885A5032324734 @default.
• W2945478885 hasAuthorship W2945478885A5033225491 @default.

• next